Author:
Hotz Julian Frederic,Staudacher Moritz,Schefberger Katharina,Spettel Kathrin,Schmid Katharina,Kriz Richard,Schneider Lisa,Hagemann Jürgen Benjamin,Cyran Norbert,Schmidt Katy,Starzengruber Peter,Lötsch Felix,Leutzendorff Amelie,Daller Simon,Ramharter Michael,Burgmann Heinz,Lagler Heimo
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520–32.
2. Kourtis AP, Hatfield K, Baggs J, Mu Y, See I, Epson E, et al. Vital signs: Epidemiology and recent trends in Methicillin-resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States. MMWR Morb Mortal Wkly Rep. 2019;68(9):214–9.
3. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.
4. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. 2023;Version 13.1.
5. Dhand A, Sakoulas G. Reduced Vancomycin susceptibility among clinical Staphylococcus aureus isolates (‘the MIC Creep’): implications for therapy. F1000. Med Rep. 2012;4:4.